GMI Among Hot 100 Startups in Ireland


This Dublin-based start-up works with the medical community to examine the human genome – also known as our complete set of DNA, including all of its genes – to better understand the role genetics play in the emergence of diseases and medical conditions.

Genomics Medicine Ireland (GMI) was established in 2015 by a group of life science entrepreneurs, investors and researchers.

It secured Series A funding of €36 million the following year from sovereign and international investors, including the Ireland Strategic Investment Fund, Arch Venture Partners, Polaris Partners and Google’s venture capital arm, GV.

The start-up recently undertook with the University of Cambridge to research the underlying genetic factors contributing to multiple sclerosis (MS).